MODERN STRATEGIES FOR EARLY DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Relevance: Cancer therapy-related cardiac dysfunction is a significant complication of cancer treatment. Conventional monitoring primarily relies on left ventricular ejection fraction (LVEF). A decrease in LVEF may indicate dysfunction only after it has already developed. Global longitudinal strain and cardiac biomarke...